Clones: 1G8.1, 2E11, 3E3.1, and GAM2.1 (BBP2020SP, BBP2019SP, BBP2018SP, and BBP2021SP respectively)  Monoclonal antibodies against IFN-gamma. Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma. IFN-gamma is produced by lymphocytes activated by specific antigens or mitogens. In addition to having antiviral activity, IFN-gamma has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.


Trial Pack of Four Interferon Gamma Monoclonal Antibodies, Size: 25 µg each

  • Tested Applications:  ELISA/WESTERN, Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma.


    Target Information:  Interferon gamma is a 19.22kDa immuno-regulatory cytokine.


    Product Format:  Affinity Purified, 1 mg/ml in Phosphate Buffered Saline. Aseptically Packaged.


    Alternate Names:  Interferon gamma, IFN gamma


    Clones:  1G8.1, 2E11, 3E3.1, GAM2.1


    Host:  Mouse


    Isotype:  IgG1


    Immunogen:  Recombinant Protein


    Specificity:  Human IFN-gamma

  • This product contains the equivalent of trial sizes of Neoclone Catalog #s N0009, N0010, N0011, and N0012 or BioLegend Catalog #s 526502, 526602, 526702, and 526802.